Anesthesia for patients on buprenorphine

Anesthesiology Clinics

Volumn 28, Issue 4, 2010, Pages 611-617

  Bryson, Ethan O ^a   Lipson, Scott ^a   Gevirtz, Clifford ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Buprenorphine; Methadone; Naloxine; Opioids

Indexed keywords

ACETYLSALICYLIC ACID; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; BUTORPHANOL; CELECOXIB; DIAMORPHINE; HYDROMORPHONE; IBUPROFEN; METHADONE; MORPHINE; NALBUPHINE; NALOXONE; NORBUPRENORPHINE; OPIATE; OPIATE RECEPTOR; OXYCODONE; PARACETAMOL; PENTAZOCINE; PREGABALIN; SEDATIVE AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANESTHESIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER PAIN; DRUG CLEARANCE; DRUG DOSE TITRATION; DRUG FORMULATION; DRUG MEGADOSE; DRUG MONITORING; DRUG SAFETY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SUBSTITUTION; FATTY LIVER; FLAPPING TREMOR; FOOD AND DRUG ADMINISTRATION; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; JAUNDICE; KIDNEY FAILURE; LIVER DISEASE; LIVER NECROSIS; OPIATE ADDICTION; PAIN; PEDIATRICS; PERIOPERATIVE PERIOD; POSTOPERATIVE PAIN; PREGNANCY; PRESCRIPTION; RESPIRATION DEPRESSION; REVIEW; RISK ASSESSMENT; SIDE EFFECT;

ANESTHESIA; BUPRENORPHINE; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; RENAL INSUFFICIENCY;

EID: 78149487688     PISSN: 19322275     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anclin.2010.08.005     Document Type: Review

References (22)

1. Raisch D.W., Fye C.L., Boardman K.D., et al. Opioid dependence treatment, including buprenorphine/naloxone. Ann Pharmacother 2002, 36:312-321.
2. Ling W. Buprenorphine for opioid dependence. Expert Rev Neurother 2009, 9(5):609-616.
3. Pleuvry B.J. The endogenous opioid system. Anaesth Pharmacol Rev 1993, 1:114-123.
4. Coda BA. Opioids. In: Barash PG, editor. Clinical anesthesia. 5th edition. Philadelphia: Lippincott; 2006. p. 353-83.
5. Inter-University Consortium for Political and Social Research. National Survey on Drug Use and Health, 2005. Available at: Accessed September 21, 2010. http://www.icpsr.umich.edu/cocoon/ICPSR/STUDY/04596.xml.
6. The Determinations Report: A Report on the Physician Waiver Program Established by the Drug Addiction Treatment Act of 2000 (" DATA" ). Available at: Accessed September 21, 2010. http://buprenorphine.samhsa.gov/SAMHSA_Determinations_Report.pdf.
7. Suboxone facts for patients [patient brochure] 2008, Reckitt Benckiser Pharmaceuticals Inc;, Richmond (VA).
8. Orman J.S., Keating G.M. Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence. Drugs 2009, 69(5):577-607.
9. Johnson R.E., Jones H.E., Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend 2003, 70(Suppl 1):S87-101.
10. Michel E., Zernikow B. Buprenorphine in children. A clinical and pharmacological review. Schmerz 2006, 20:40-50.
11. Geib A.J., Babu K., Burns M., et al. Adverse effects in children after unintentional buprenorphine exposure. Pediatrics 2006, 118:1746-1751.
12. Hand C.W., Sear J.W., Uppington J. Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites. Br J Anaesth 1990, 64:276-282.
13. Berson A., Gervais A., Cazals D., et al. Hepatitis after intravenous buprenorphine misuse in heroin addicts. J Hepatol 2001, 34:346-350.
14. Petry N.M., Bickel W.K., Piasecki D., et al. Elevated liver enzyme levels in opioid-dependent patients with hepatitis treated with buprenorphine. Am J Addict 2000, 9:265-269.
15. Jones H.E., Johnson R.E., Milio L. Post-cesarean pain management of patients maintained on methadone or buprenorphine. Am J Addict 2006, 15(3):258-259.
16. Book S.W., Myrick H., Malcolm R., et al. Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient. Am J Psychiatry 2007, 164:979.
17. Alford D.P., Compton P., Samet J.H. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med 2006, 144(2):127-134.
18. Robert D.M., Meyer-Witting M. High-dose buprenorphine: perioperative precautions and management strategies. Anaesth Intensive Care 2005, 33:17-25.
19. Schuh K.J., Walsh S.L., Stitzerr M.L. Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans. Psychopharmacology 1999, 145:162-174.
20. ®). Addiction 2008, 103:1226-1228.
21. Dalouede J.P., Caer Y., Galland P., et al. Preference for buprenorphine/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: a prospective, multicenter study. J Subst Abuse Treat 2010, 38(1):83-89.
22. Martine-Raga J., Gonzalez Salz F., Pascual C., et al. Suboxone (buprenorphine/naloxone) as an agonist opioid treatment in Spain: a budgetary impact analysis. Eur Addict Res 2010, 16(1):31-42.